drug
eravacycline dihydrochloride
Marketedupdated 3mo agoby La Jolla Pharmaceutical Company
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 27, 2028
~2.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Oct 19, 2037compositionUS 10961190
- Oct 19, 2037compositionUS 10961190
- Oct 19, 2037compositionUS 11578044
- Oct 19, 2037compositionUS 11578044
- Dec 28, 2030formulationUS 89068874.4y
- Dec 28, 2030formulationUS 89068874.4y
- Aug 7, 2029method-of-use (U-2380)US 87962453.0y
- Aug 7, 2029method-of-use (U-2380)US 87962453.0y
FDA exclusivities (4)
- Aug 27, 2028GAINGAIN Antibiotic (5y)2.1y
- Aug 27, 2028GAINGAIN Antibiotic (5y)2.1y
- Aug 27, 2023NCENew Chemical Entity (5y)
- Aug 27, 2023NCENew Chemical Entity (5y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that